Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Armata Pharmaceuticals Inc. sell Lokrim

Start price
€2.22
17.08.24 / 20%
Target price
-
17.08.25
Performance (%)
-6.31%
End price
€2.08
18.08.25
Summary
This prediction ended on 18.08.25 with a price of €2.08. With a performance of -6.31%, the SELL prediction for Armata Pharmaceuticals Inc. by Lokrim was down slightly. Lokrim has 20% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Armata Pharmaceuticals Inc. -2.178% -2.178% -
iShares Core DAX® 0.734% 1.458% 17.980%
iShares Nasdaq 100 -2.686% -0.146% 3.810%
iShares Nikkei 225® -2.261% -2.729% 11.679%
iShares S&P 500 -1.346% 0.467% 1.970%

According to Lokrim what are the pros and cons of Armata Pharmaceuticals Inc. for the foreseeable future?

Pros
Cons
Revenue decline/stagnation expected
Risky Investment

Comments by Lokrim for this prediction

In the thread Armata Pharmaceuticals Inc. diskutieren

Sell Armata Pharmaceuticals Inc.

In the thread Trading Armata Pharmaceuticals Inc.
Prediction Sell
Perf. (%) -6.31%
Target price
Change
Ends at 17.08.25

Die von Lokrim gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Lokrim for Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.02
09.07.23
-
09.07.24
123.53%
11.12.23

Probably not worthwhile Investment